Sierra Oncology (SRRA) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free SRRA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSierra Space eyes IPO market as it braces for a 'profound industrial revolution' in spacemsn.com - April 11 at 7:47 PMSierra Oncology Inc.thestreet.com - February 21 at 6:31 AMSierra Coupon for Octobertime.com - November 9 at 8:15 PMFDA approves GSK's unique myelofibrosis treatment Ojjaaramsn.com - September 18 at 6:25 PMPleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Dealmsn.com - September 18 at 8:07 AMFDA approves GSK's Ojjaara for treatment of myelofibrosis-related anaemiamsn.com - September 18 at 8:07 AMAnalyst calls of the week: Palo Alto upped, Carnival earnings preview and moreproactiveinvestors.com - June 16 at 5:51 PMSierra Oncology (NASDAQ: SRRA)fool.com - June 12 at 2:06 AMCelyad Oncology Stock (NASDAQ:CYAD), Quotes and News Summarybenzinga.com - February 25 at 4:55 PMSierra Leonebbc.co.uk - February 22 at 8:55 AMInterventional Oncology Global Market - Forecast To 2029finance.yahoo.com - January 20 at 11:27 PMGSK Signs Deal to Develop Antibodies for Treating Cancernasdaq.com - January 5 at 8:23 PMSareum Holdings Says Sierra Oncology To Return Cancer Treatment License; Shares Fallmarketwatch.com - October 12 at 10:30 AMCompanion Diagnostic Tests in Oncology Market 2022 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2027marketwatch.com - September 25 at 1:46 PM15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferiesthestreet.com - September 1 at 11:33 PMSierra Leone passes new laws to boost landowners' rightsyahoo.com - August 8 at 4:24 PMSareum Holdings Says GSK Completes Acquisition of Sierra Oncologymarketwatch.com - July 4 at 4:08 AMmarketbeat.com - July 1 at 6:04 AMSierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administrationfinance.yahoo.com - June 17 at 5:56 PMSierra Oncology hits 52w high – but will it continue?uk.finance.yahoo.com - June 13 at 5:39 AMSierra Oncology, Inc. (NASDAQ:SRRA) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - June 3 at 6:29 AMMomelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meetingfinance.yahoo.com - May 26 at 6:08 PM-$0.95 Earnings Per Share Expected for Sierra Oncology, Inc. (NASDAQ:SRRA) This Quartermarketbeat.com - May 22 at 6:16 PMSierra Oncology (NASDAQ:SRRA) Downgraded to Hold at Zacks Investment Researchmarketbeat.com - May 18 at 9:53 AMShort Interest in Sierra Oncology, Inc. (NASDAQ:SRRA) Decreases By 55.9%marketbeat.com - May 13 at 6:55 AMSierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meetingfinance.yahoo.com - May 12 at 1:28 PMSierra Oncology, Inc. (NASDAQ:SRRA) Receives Consensus Rating of "Hold" from Analystsmarketbeat.com - May 9 at 6:20 AMSierra Oncology Reports First Quarter 2022 Resultsfinance.yahoo.com - May 6 at 8:05 AMSIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRAstockhouse.com - May 2 at 6:01 PMBiotech Stock Roundup: SRRA Surges on GSK Buyout, HALO Offers Update & Moremsn.com - April 14 at 3:01 PMAnalyzing Sierra Oncology Inc's Short Interestmsn.com - April 14 at 10:01 AMAnalyst Ratings for Sierra Oncologymarkets.businessinsider.com - April 14 at 10:01 AMSHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc.prnewswire.com - April 13 at 3:24 PMGlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash Dealfinance.yahoo.com - April 13 at 3:22 PMSierra Oncology Stock Is Soaring: Here's Whymarkets.businessinsider.com - April 13 at 3:22 PMWhy Is Sierra Oncology (SRRA) Stock Up Today?investorplace.com - April 13 at 12:02 PMGlaxoSmithKline to buy Sierra Oncology for $1.9 billionmsn.com - April 13 at 10:21 AMGSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnfinance.yahoo.com - April 13 at 10:21 AMGSK Agrees To Acquire Sierra Oncology For $1.9 Blnnasdaq.com - April 13 at 10:21 AMSRRA Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sierra Oncology, Inc. Is Fair to Shareholderstmcnet.com - April 13 at 10:21 AMGSK to buy Sierra Oncology for $1.9 bln in boost to blood cancer opsreuters.com - April 13 at 10:21 AMSierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoSmithKlinebarrons.com - April 13 at 10:21 AMSierra Oncology Stock Soars After $1.9 Billion Takeover by Glaxofinance.yahoo.com - April 13 at 10:21 AMBiotech Feeding Spree As GSK, Halozyme Announce Nearly $3 Billion In Dealsfinance.yahoo.com - April 13 at 10:21 AMOppenheimer Increases Sierra Oncology (NASDAQ:SRRA) Price Target to $45.00marketbeat.com - March 14 at 7:41 AMSierra Oncology Non-GAAP EPS of -$1.44seekingalpha.com - March 11 at 8:38 PMSierra Oncology Reports 2021 Year End Resultsfinance.yahoo.com - March 10 at 8:12 AMHarley-Davidson, SOC Telemed Stocks See Action From Activist Investorsfinance.yahoo.com - February 12 at 12:14 AMSierra Oncology raises additional funds from underwriters of stock offeringseekingalpha.com - February 3 at 8:55 PMSierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - February 3 at 8:55 PM Get Sierra Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SRRA and its competitors with MarketBeat's FREE daily newsletter. Email Address My top 100 stocks… (Ad)We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well. Get some cool freebies right here. SRRA Media Mentions By Week SRRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRRA News Sentiment▼0.000.32▲Average Medical News Sentiment SRRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRRA Articles This Week▼00▲SRRA Articles Average Week Get Sierra Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SRRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Gyre Therapeutics News Ironwood Pharmaceuticals News ANI Pharmaceuticals News Arcus Biosciences News Verona Pharma News Kura Oncology News Kiniksa Pharmaceuticals News Morphic News Pacira BioSciences News Spyre Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRRA) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sierra Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
